• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)开放阅读框7a(ORF7a)跨膜结构域中的保守替换作为冠状病毒病(COVID-19)的一个潜在危险因素

A Conservative Replacement in the Transmembrane Domain of SARS-CoV-2 ORF7a as a Putative Risk Factor in COVID-19.

作者信息

Lobiuc Andrei, Șterbuleac Daniel, Sturdza Olga, Dimian Mihai, Covasa Mihai

机构信息

Department of Biomedical Sciences, College of Medicine and Biological Sciences, "Ștefan cel Mare" University of Suceava, Str. Universității 13, 720229 Suceava, Romania.

Division of Infectious Diseases, Suceava County Regional Emergency Hospital, 720229 Suceava, Romania.

出版信息

Biology (Basel). 2021 Dec 5;10(12):1276. doi: 10.3390/biology10121276.

DOI:10.3390/biology10121276
PMID:34943191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8698902/
Abstract

The ongoing COVID-19 pandemic follows an unpredictable evolution, driven by both host-related factors such as mobility, vaccination status, and comorbidities and by pathogen-related ones. The pathogenicity of its causative agent, SARS-CoV-2 virus, relates to the functions of the proteins synthesized intracellularly, as guided by viral RNA. These functions are constantly altered through mutations resulting in increased virulence, infectivity, and antibody-evasion abilities. Well-characterized mutations in the spike protein, such as D614G, N439K, Δ69-70, E484K, or N501Y, are currently defining specific variants; however, some less studied mutations outside the spike region, such as p. 3691 in NSP6, p. 9659 in ORF-10, 8782C > T in ORF-1ab, or 28144T > C in ORF-8, have been proposed for altering SARS-CoV-2 virulence and pathogenicity. Therefore, in this study, we focused on A105V mutation of SARS-CoV-2 ORF7a accessory protein, which has been associated with severe COVID-19 clinical manifestation. Molecular dynamics and computational structural analyses revealed that this mutation differentially alters ORF7a dynamics, suggesting a gain-of-function role that may explain its role in the severe form of COVID-19 disease.

摘要

当前的新冠疫情发展态势难以预测,这是由宿主相关因素(如流动性、疫苗接种状况和合并症)以及病原体相关因素共同驱动的。其病原体严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒的致病性与病毒RNA指导下在细胞内合成的蛋白质功能有关。这些功能通过突变不断改变,导致毒力、传染性和抗体逃避能力增强。刺突蛋白中特征明确的突变,如D614G、N439K、Δ69-70、E484K或N501Y,目前正在定义特定的变体;然而,刺突区域外一些研究较少的突变,如非结构蛋白6(NSP6)中的p. 3691、开放阅读框10(ORF-10)中的p. 9659、开放阅读框1ab(ORF-1ab)中的8782C>T或开放阅读框8(ORF-8)中的28144T>C,已被提出可改变SARS-CoV-2的毒力和致病性。因此,在本研究中,我们聚焦于SARS-CoV-2 ORF7a辅助蛋白的A105V突变,该突变与严重的新冠临床表现相关。分子动力学和计算结构分析表明,这种突变以不同方式改变了ORF7a的动力学,提示其功能获得作用,这可能解释了它在严重形式的新冠疾病中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/8698902/8271a232d64b/biology-10-01276-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/8698902/5ccabf6a67a6/biology-10-01276-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/8698902/da9d05cb9a6d/biology-10-01276-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/8698902/d731418ea5ce/biology-10-01276-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/8698902/2962862ebce4/biology-10-01276-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/8698902/8271a232d64b/biology-10-01276-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/8698902/5ccabf6a67a6/biology-10-01276-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/8698902/da9d05cb9a6d/biology-10-01276-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/8698902/d731418ea5ce/biology-10-01276-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/8698902/2962862ebce4/biology-10-01276-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/8698902/8271a232d64b/biology-10-01276-g005.jpg

相似文献

1
A Conservative Replacement in the Transmembrane Domain of SARS-CoV-2 ORF7a as a Putative Risk Factor in COVID-19.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)开放阅读框7a(ORF7a)跨膜结构域中的保守替换作为冠状病毒病(COVID-19)的一个潜在危险因素
Biology (Basel). 2021 Dec 5;10(12):1276. doi: 10.3390/biology10121276.
2
Understanding how transmembrane domains regulate interactions between human BST-2 and the SARS-CoV-2 accessory protein ORF7a.解析人类 BST-2 跨膜结构域与 SARS-CoV-2 辅助蛋白 ORF7a 相互作用的机制。
Biochim Biophys Acta Biomembr. 2023 Aug;1865(6):184174. doi: 10.1016/j.bbamem.2023.184174. Epub 2023 May 19.
3
Temporal-Geographical Dispersion of SARS-CoV-2 Spike Glycoprotein Variant Lineages and Their Functional Prediction Using Approach.利用 方法预测 SARS-CoV-2 刺突糖蛋白变异株的时空地理分布及其功能。
mBio. 2021 Oct 26;12(5):e0268721. doi: 10.1128/mBio.02687-21.
4
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
5
Ubiquitination of SARS-CoV-2 ORF7a Prevents Cell Death Induced by Recruiting BclXL To Activate ER Stress.冠状病毒 2 型 ORF7a 的泛素化通过募集 BclXL 激活内质网应激来防止细胞死亡。
Microbiol Spectr. 2022 Dec 21;10(6):e0150922. doi: 10.1128/spectrum.01509-22. Epub 2022 Nov 3.
6
Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene.关注的 B.1.351 和 B.1.1.7 SARS-CoV-2 变异株的复制动力学,包括评估携带 ORF7a 基因缺陷的 B.1.1.7 突变体。
Viruses. 2021 Jun 7;13(6):1087. doi: 10.3390/v13061087.
7
Computational decomposition reveals reshaping of the SARS-CoV-2-ACE2 interface among viral variants expressing the N501Y mutation.计算分解揭示了表达 N501Y 突变的 SARS-CoV-2-ACE2 界面在病毒变异体中的重塑。
J Cell Biochem. 2021 Dec;122(12):1863-1872. doi: 10.1002/jcb.30142. Epub 2021 Sep 13.
8
Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein.基于刺突蛋白的进化动态和特定病毒突变对 SARS-CoV-2 全球传播的特征分析。
Infect Dis Poverty. 2021 Aug 21;10(1):112. doi: 10.1186/s40249-021-00895-4.
9
Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.宿主对 SARS-CoV2 及现有肝脏和胃肠道疾病中新兴变异株的反应。
Front Cell Infect Microbiol. 2021 Oct 25;11:753249. doi: 10.3389/fcimb.2021.753249. eCollection 2021.
10
SARS-CoV-2 ORF7a blocked autophagy flux by intervening in the fusion between autophagosome and lysosome to promote viral infection and pathogenesis.SARS-CoV-2 的 ORF7a 通过干预自噬体与溶酶体之间的融合来阻断自噬流,从而促进病毒感染和发病机制。
J Med Virol. 2023 Nov;95(11):e29200. doi: 10.1002/jmv.29200.

引用本文的文献

1
A comprehensive review of current insights into the virulence factors of SARS-CoV-2.对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)毒力因子当前见解的全面综述。
J Virol. 2025 Feb 25;99(2):e0204924. doi: 10.1128/jvi.02049-24. Epub 2025 Jan 29.
2
SARS-CoV-2 ORF7a Mutation Found in BF.5 and BF.7 Sublineages Impacts Its Functions.SARS-CoV-2 ORF7a 突变在 BF.5 和 BF.7 亚谱系中被发现,影响其功能。
Int J Mol Sci. 2024 Feb 16;25(4):2351. doi: 10.3390/ijms25042351.
3
Persistence of a Frameshifting Deletion in SARS-CoV-2 ORF7a for the Duration of a Major Outbreak.

本文引用的文献

1
Introduction and Characteristics of SARS-CoV-2 in North-East of Romania During the First COVID-19 Outbreak.罗马尼亚东北部首次新冠疫情期间严重急性呼吸综合征冠状病毒2的介绍与特征
Front Microbiol. 2021 Jul 7;12:654417. doi: 10.3389/fmicb.2021.654417. eCollection 2021.
2
Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)和严重急性呼吸综合征冠状病毒(SARS-CoV)主要蛋白的结构与功能
Bioinform Biol Insights. 2021 Jun 22;15:11779322211025876. doi: 10.1177/11779322211025876. eCollection 2021.
3
SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression.
SARS-CoV-2 ORF7a 框移缺失在一次重大疫情中的持续存在。
Viruses. 2023 Feb 13;15(2):522. doi: 10.3390/v15020522.
4
Genomic surveillance of SARS-CoV-2 positive passengers on flights from China to Italy, December 2022.2022 年 12 月从中国飞往意大利航班上 SARS-CoV-2 阳性乘客的基因组监测。
Euro Surveill. 2023 Jan;28(2). doi: 10.2807/1560-7917.ES.2023.28.2.2300008.
5
SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression.SARS-CoV-2 的辅助蛋白 ORF7a 和 ORF3a 使用不同的机制下调 MHC-I 表面表达。
Proc Natl Acad Sci U S A. 2023 Jan 3;120(1):e2208525120. doi: 10.1073/pnas.2208525120. Epub 2022 Dec 27.
6
Coronavirus Disease 2019 (COVID-19).2019冠状病毒病(COVID-19)
Biology (Basel). 2022 Aug 22;11(8):1250. doi: 10.3390/biology11081250.
7
Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency.识别继发性免疫缺陷患者中新兴的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的标志物。
Front Microbiol. 2022 Jul 1;13:933983. doi: 10.3389/fmicb.2022.933983. eCollection 2022.
8
Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan.乌兹别克斯坦临床样本中获得的 SARS-CoV-2 的基因组序列多样性。
PLoS One. 2022 Jun 27;17(6):e0270314. doi: 10.1371/journal.pone.0270314. eCollection 2022.
9
SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to downregulate MHC-I surface expression.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)辅助蛋白ORF7a和ORF3a利用不同机制下调主要组织相容性复合体I类(MHC-I)分子的表面表达。
bioRxiv. 2022 May 17:2022.05.17.492198. doi: 10.1101/2022.05.17.492198.
10
A 336-nucleotide in-frame deletion in ORF7a gene of SARS-CoV-2 identified in genomic surveillance by next-generation sequencing.通过下一代测序在基因组监测中鉴定出的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)ORF7a基因中的一个336个核苷酸的框内缺失。
J Clin Virol. 2022 Mar;148:105105. doi: 10.1016/j.jcv.2022.105105. Epub 2022 Feb 14.
SARS-CoV-2 基因组监测发现 ORF7a 自然发生的截断,限制了免疫抑制。
Cell Rep. 2021 Jun 1;35(9):109197. doi: 10.1016/j.celrep.2021.109197. Epub 2021 May 14.
4
Insight into the LFA-1/SARS-CoV-2 Orf7a Complex by Protein-Protein Docking, Molecular Dynamics, and MM-GBSA Calculations.通过蛋白-蛋白对接、分子动力学和 MM-GBSA 计算深入了解 LFA-1/SARS-CoV-2 Orf7a 复合物。
J Chem Inf Model. 2021 Jun 28;61(6):2780-2787. doi: 10.1021/acs.jcim.1c00198. Epub 2021 May 27.
5
Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the ACE2 Receptor.分子对接和动力学模拟揭示了血管紧张素转换酶抑制剂针对血管紧张素转换酶2受体对严重急性呼吸综合征冠状病毒2的潜在抑制活性。
Front Chem. 2021 May 4;9:661230. doi: 10.3389/fchem.2021.661230. eCollection 2021.
6
Functional landscape of SARS-CoV-2 cellular restriction.SARS-CoV-2 细胞限制的功能景观
Mol Cell. 2021 Jun 17;81(12):2656-2668.e8. doi: 10.1016/j.molcel.2021.04.008. Epub 2021 Apr 13.
7
Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14 monocytes.结构洞察揭示新冠病毒ORF7a作为人类CD14单核细胞的免疫调节因子。
iScience. 2021 Mar 19;24(3):102187. doi: 10.1016/j.isci.2021.102187. Epub 2021 Feb 12.
8
A deletion in SARS-CoV-2 ORF7 identified in COVID-19 outbreak in Uruguay.在乌拉圭 COVID-19 疫情中发现的 SARS-CoV-2 ORF7 缺失。
Transbound Emerg Dis. 2021 Nov;68(6):3075-3082. doi: 10.1111/tbed.14002. Epub 2021 Mar 5.
9
Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response.新型冠状病毒ORF7a的泛素化促进对干扰素反应的拮抗作用。
Cell Mol Immunol. 2021 Mar;18(3):746-748. doi: 10.1038/s41423-020-00603-6. Epub 2021 Jan 20.
10
Structural assessment of SARS-CoV2 accessory protein ORF7a predicts LFA-1 and Mac-1 binding potential.SARS-CoV2 辅助蛋白 ORF7a 的结构评估预测了 LFA-1 和 Mac-1 的结合潜力。
Biosci Rep. 2021 Jan 29;41(1). doi: 10.1042/BSR20203837.